Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

SHE:002873 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	169.43	118.16	138.24	100.67	72.48	330.09
Trading Asset Securities	0.1	0.12	0.09	0.11	80	118
Cash & Short-Term Investments	169.53	118.28	138.33	100.78	152.48	448.09
Cash Growth	23.91%	-14.49%	37.26%	-33.91%	-65.97%	146.67%
Accounts Receivable	263.85	325.67	250.54	261.96	282.72	249.96
Other Receivables	24.1	22.09	48.22	42.12	21.52	18.16
Receivables	287.95	347.77	298.76	304.08	304.24	268.13
Inventory	180.45	145.48	184.33	183.34	118.77	86.82
Other Current Assets	15.9	5.28	15	22.44	11.34	9.85
Total Current Assets	653.83	616.81	636.43	610.65	586.83	812.88
Property, Plant & Equipment	686.4	708.83	706.3	593.75	463.94	381.09
Long-Term Investments	530.34	412.07	383.27	461.57	312.5	183.64
Other Intangible Assets	108.33	108.96	83.52	86.1	87.51	79.51
Long-Term Deferred Tax Assets	10.66	10.06	10.33	13.46	11.26	12.6
Long-Term Deferred Charges	98.42	90.36	88.45	70.39	58.67	62.39
Other Long-Term Assets	4.95	3.41	3.5	3.6	3.71	3.81
Total Assets	2,093	1,951	1,912	1,840	1,524	1,536
Accounts Payable	106.89	83.36	105.08	95.67	64.89	44.81
Accrued Expenses	22.88	48.91	31.8	39.71	53.85	43.38
Short-Term Debt	59.02	306.24	366.93	317.37	268.34	402.02
Current Portion of Long-Term Debt	73.54	20.8	26.03	5.01	-	2.46
Current Portion of Leases	-	4.97	4.16	1.4	-	-
Current Income Taxes Payable	16.62	0.03	0	2.29	4.72	3.71
Current Unearned Revenue	0.66	0.52	1	13.86	15.36	7.9
Other Current Liabilities	22.16	16.55	20.42	26.4	34.07	9.36
Total Current Liabilities	301.76	481.38	555.42	501.69	441.23	513.64
Long-Term Debt	463.24	221.4	195.54	156.68	154.79	159.95
Long-Term Leases	6.15	6.77	9.35	5.72	6.65	-
Long-Term Unearned Revenue	24.12	23.58	20.83	22.15	24.51	24
Long-Term Deferred Tax Liabilities	33.82	22.11	16.72	27.99	3.38	6.55
Other Long-Term Liabilities	0.53	0.55	0.59	3.36	3.42	3.5
Total Liabilities	829.62	755.79	798.47	717.59	633.98	707.64
Common Stock	244.1	244.1	231.49	231.97	164.05	117.15
Additional Paid-In Capital	282.35	282.35	179.72	187	220.67	281.76
Retained Earnings	667.39	665.32	637.57	579.88	490.94	404.35
Treasury Stock	-75.3	-75.3	-9.54	-17.61	-27.81	-35.6
Comprehensive Income & Other	144.77	78.24	74.09	140.69	42.61	60.63
Total Common Equity	1,263	1,195	1,113	1,122	890.44	828.3
Shareholders' Equity	1,263	1,195	1,113	1,122	890.44	828.3
Total Liabilities & Equity	2,093	1,951	1,912	1,840	1,524	1,536
Total Debt	601.95	560.18	602.01	486.17	429.79	564.43
Net Cash (Debt)	-432.42	-441.9	-463.68	-385.39	-277.31	-116.35
Net Cash Per Share	-1.88	-2.01	-1.90	-1.58	-1.13	-0.48
Filing Date Shares Outstanding	235.3	235.3	231.4	231.89	228.31	225.3
Total Common Shares Outstanding	235.3	235.3	231.4	231.89	228.31	225.3
Working Capital	352.07	135.43	81	108.96	145.59	299.24
Book Value Per Share	5.37	5.08	4.81	4.84	3.90	3.68
Tangible Book Value	1,155	1,086	1,030	1,036	802.93	748.78
Tangible Book Value Per Share	4.91	4.61	4.45	4.47	3.52	3.32
Buildings	-	628.65	639.78	369.03	327.11	293.66
Machinery	-	177.35	167.14	121.47	92.52	84.84
Construction In Progress	-	55.81	33.72	228.36	151.22	99.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.